HNN3.0

Project cooperationUpdated on 20 January 2026

Personalized CVD care

Project Manager at Verlab Research Institute

Sarajevo, Bosnia And Herzegovina

About

I am the Action Chair of COST Action CardioPharmaGENET (Network for Cardiovascular Pharmacogenomics and Precision Medicine) and hold a PhD degree in personalized anticoagulant therapy. With a network of academic and clinical partners, I offer an excellent possibility of improving the quality of the proposal to the consortium and would be interested to act as active partner in writing, submitting and implementing the proposal.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

Organisation

Verlab Research Institute

R&D Institution

Sarajevo, Bosnia And Herzegovina

Similar opportunities

  • Project cooperation

    HORIZON-HLTH-2026-01-DISEASE-11 Collaboration Offer

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Elif Yıldırım

    R&D Specialist at Dogus Bilgi Islem ve Teknoloji Hizmetleri A.S.

    İstanbul, Türkiye

  • Project cooperation

    HORIZON-HLTH-2026-01-DISEASE-02 Collaboration Offer

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Setenay Gemici Öztürk

    Research and Development Specialist at Dogus Bilgi Islem ve Teknoloji Hizmetleri A.S.

    İstanbul, Türkiye

  • Project cooperation

    AI4CardioGender

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Angelo Aloia

    Open Innovation Manager at Relatech S.p.A.

    Milano, Italy